Clinical Trial Update: Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia [Phase 2]

View source ↗

Summary

A Phase II trial testing multi-dosing Bacillus Calmette-Guérin (BCG) vaccine for fibromyalgia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Fibromyalgia | Phase 2 | Status: WITHDRAWN